Cargando…
Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma
AIM: To investigate the factors influenced the efficacy of tolvaptan (TLV) in liver cirrhosis. METHODS: We retrospectively enrolled 61 consecutive patients with refractory hepatic ascites. All of them had been treated with furosemide and spironolactone before admission, and treated with TLV for 7 d...
Autores principales: | Miyazaki, Masayuki, Yada, Masayoshi, Tanaka, Kosuke, Senjyu, Takeshi, Goya, Takeshi, Motomura, Kenta, Kohjima, Motoyuki, Kato, Masaki, Masumoto, Akihide, Kotoh, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550787/ https://www.ncbi.nlm.nih.gov/pubmed/28839438 http://dx.doi.org/10.3748/wjg.v23.i29.5379 |
Ejemplares similares
-
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
por: Yada, Masayoshi, et al.
Publicado: (2018) -
FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy
por: Kuwano, Akifumi, et al.
Publicado: (2023) -
Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma: Anticipated Usefulness in Clinical Practice
por: Motomura, Kenta, et al.
Publicado: (2023) -
Tumor‑infiltrating CD8(+) T cells as a biomarker for chemotherapy efficacy in unresectable hepatocellular carcinoma
por: Kuwano, Akifumi, et al.
Publicado: (2023) -
Therapeutic efficacy of lenvatinib for hepatocellular carcinoma with iso-high intensity in the hepatobiliary phase of Gd-EOB-DTPA-MRI
por: Kuwano, Akifumi, et al.
Publicado: (2022)